Cool Solutions: Non-Hormonal Advances in Vasomotor Symptoms Treatment

1.0 Credits / Women's Health

Treating MASH in 2026: Guideline-Directed Care and Emerging Therapeutic Strategies

1.0 Credit / Gastroenterology

Translating KDIGO Updates and Clinical Evidence Into Managed Care Decision-Making in IgA Nephropathy

Thursday, July 30, 2026 | 1:00 PM & 8:00 PM ET

Implementing Pharmacist-Led Strategies to Support Comprehensive MASH Management

1.0 Credit / Gastroenterology

Metabolic Drivers of MASLD/MASH: Understanding the Disease and Identifying At-Risk Patients

1.0 Credit / Gastroenterology

Bridging Gaps in Meningococcal Protection: Pharmacist-Led Approaches to Vaccination and Public Health Equity

1.5 Credits / Dermatology

Evolving Role of CGM in Diabetes Care: What’s New in 2026 (Pharmacy Technician Credit)

1.0 Credit / Endocrinology, Diabetes & Metabolism

Optimizing CGM and CKM Data Across Populations, Interpretation, Integration, and Clinical Decision-Making (Pharmacy Technician Credit)

1.5 Credit / Endocrinology, Diabetes & Metabolism

Optimizing CGM and CKM Data Across Populations, Interpretation, Integration, and Clinical Decision-Making

1.5 Credit / Endocrinology, Diabetes & Metabolism

CGM Insights to Address Common Questions (Pharmacy Technician Credit)

0.5 Credit / Endocrinology, Diabetes & Metabolism

CGM Insights to Address Common Questions

0.5 Credit / Endocrinology, Diabetes & Metabolism

Leveraging CGM Data & Digital Tools (Pharmacy Technician Credit)

1.0 Credit / Endocrinology, Diabetes & Metabolism

Leveraging CGM Data & Digital Tools

1.0 Credit / Endocrinology, Diabetes & Metabolism

Evolving Role of CGM in Diabetes Care: What’s New in 2026

1.0 Credit / Endocrinology, Diabetes & Metabolism

Outsmart the Algorithm: Combatting Misinformation at the Pharmacy Counter

Monday, July 22, 2026 | 1:00 PM & 8:00 PM

Navigating Asparaginase-Based Therapies in Adult, Adolescent, and Young Adult Acute Lymphoblastic Leukemia: Evidence-Based Guidance for the Oncology Pharmacist

1.25 Credit / Hematology, Hematologic Cancer

Personalizing Breast Cancer Care: Pharmacist Strategies for Optimizing Oral Therapy Outcomes

1.5 Credit / Breast Cancer

Optimizing Care for Patients With Lupus Nephritis

1.5 Credit / General Pharmacy

Wake Up to Change: New Targets and Therapeutic Strategies in Narcolepsy

1.5 Credit / Dermatology

NEIAP 2026 Annual Forum

Friday, September 11, 2026

Improving the Identification and Management of Fibrosing Interstitial Lung Diseases Through the Power of the Multidisciplinary Care Team

1.5 Credit / Dermatology

Advancing Patient-Centered Care in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema Through Specialty Pharmacy Support

1.5 Credit / Immunology

Applying Value-Based Principles in ATTR-CM Care: Optimizing Identification, Therapy Selection, and Patient Access

1.5 Credit / Cardiology

On the Pulse of Progress: Applying Ovarian Cancer Advances Across the Pharmacy Spectrum

1.5 Credits / Gynecologic Cancer, Oncology, Women's Health

Optimizing Specialty Pharmacy Practice in HER2-Altered Non-Small Cell Lung Cancer: Testing, Treatment, and Access

1.5 Credit / Immunology

Pipeline to Practice in Platinum-Resistant Ovarian Cancer: What's New, What's Next, and How to Prepare

1.0 Credit / Gynecologic Cancer, Oncology, Women's Health

TL1A Inhibitors in Inflammatory Bowel Disease: New Clinical Insights and Access Considerations for Managed Care and Specialty Pharmacy

1.5 Credit / Immunology

Enhancing Patient Outcomes in Metastatic Colorectal Cancer: Equipping Community, Veterans Affairs, and Oncology Pharmacists to Navigate Care in the Third-Line Setting and Beyond

Tuesday, June 30, 2026 | 1:00 PM & 8:00 PM EDT

Navigating Complexities in Chronic Lymphocytic Leukemia Therapy: A Practical Guide for Community Oncology Pharmacists

0.75 Credit / Oncology

Advancing Pharmacist-Led Care in Chronic Myeloid Leukemia: Bridging Knowledge and Practice Gaps to Optimize Tyrosine Kinase Inhibitor Management and Patient Adherence

0.75 Credit / Oncology

Advancing Community Oncology Practice: Pharmacist-Led Strategies for Biomarker-Driven Treatment in Non–Small Cell Lung Cancer

0.75 Credit / Oncology

Communication in Action: Empowering Community Oncology Pharmacists to Optimize Prostate Cancer Care Across Urology and Oncology

0.75 Credit / Oncology

The Art of the Possible: Strengthening the Community Pharmacist’s Involvement in Operational Workflows for Bispecific Antibody Therapy in Non-Hodgkin Lymphoma

0.75 Credit / Oncology

Targeting Genomic Drivers to Optimize ROS1-Directed Therapy in NSCLC

Thursday, June 18, 2026 | 1:00 PM - 2:00 PM CT

From Molecule to Medication: Integrating Menin Inhibitors in AML Practice

Friday, June 19, 2026 | 7:00 AM - 8:00 AM CT

Not All Bispecifics Are Equal: Mechanism-Based Approaches to Selection and Management in Oncology Practice

Thursday, June 18, 2026 | 7:00 AM - 8:00 AM CT

The Expanding Psoriasis Treatment Landscape: Leveraging the Pharmacist's Role in Patient Care to Improve Access and Outcomes for TYK Inhibitors

1.5 Credit / Dermatology, Immunology

From Crisis Aversion to Cost Reduction - Managed Care Insights on Enhancing Ketone Monitoring for Diabetic Ketoacidosis Prevention

3.0 Credits / Endocrinology, Diabetes & Metabolism

Myeloma Day of Education 2026

Tuesday, December 1, 2026

Stimulant Stewardship: A Pharmacist’s Guide to ADHD Prescribing During Drug Shortages

Monday, June 15, 2026 | 1:00 PM & 8:00 PM EDT

From Evidence to Access: Integrating SGLT2 Inhibitors Across the Cardiorenal-Metabolic Continuum

Thursday, June 25, 2026 | 1:00 PM & 8:00 PM ET

Homeopathy in Oncology Supportive Care: The Pharmacist’s Role in Integrating Patient-Centered Strategies for Chemotherapy-Related Symptom Management (Pharmacy Technician Credit)

2.0 Credits / Oncology

Homeopathy in Oncology Supportive Care: The Pharmacist’s Role in Integrating Patient-Centered Strategies for Chemotherapy-Related Symptom Management (Pharmacist Credit)

2.0 Credits / Oncology

Engineering Better Outcomes: Mechanisms, Evidence, and Operations for Next-Generation Graft-versus-Host Disease Prevention

1.5 Credit / Hematologic Cancer, Hematology

Optimizing Outcomes in Hereditary Angioedema: Managed Care Approaches to Diagnosis, Treatment, and Patient Quality of Life

1.5 Credit / Immunology

Integrating Therapeutic Advances and Value-Based Models in Myasthenia Gravis Management

1.5 Credit / Neurology

Optimizing HER2-Targeted Therapies in Non-Small Cell Lung Cancer: A Pharmacist’s Guide to Biomarker Testing, Therapeutic Selection, and Toxicity Management

1.5 Credit / Oncology, Lung Cancer

Optimizing Cardiorenal-Metabolic Health: A Managed Care Guide to Integrating SGLT2 Inhibitor Therapy

1.5 Credit / Endocrinology, Diabetes & Metabolism